Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zonisamide for prevention of atypical antipsychotic-associated weight gain in schizophrenia
IRCT201103283930N5Phase 2Completed
- Sponsor
- Shiraz University of Medical Sciences
- Start
- Mar 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of zonisamide in schizophrenia, sponsored by Shiraz University of Medical Sciences. Started Mar 2011; status: completed.
02
Drugs
zonisamide
03
Conditions
schizophrenia
Beyond the preview
Go deeper on IRCT201103283930N5.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201103283930N5.